Loading…
Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved the fertility and ovarian function of perimenopausal mice undergoing natural aging
Currently, no approved stem cell-based therapies for preserving ovarian function during aging. To solve this problem, we developed a long-term treatment for human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs). We investigated whether the cells retained their ability to resist...
Saved in:
Published in: | Stem cell research & therapy 2024-03, Vol.15 (1), p.58-58, Article 58 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c580t-481918e2f46e5d176d9f52319fa1f0bafe872e6f7fba08c00272a7aab544ff3c3 |
container_end_page | 58 |
container_issue | 1 |
container_start_page | 58 |
container_title | Stem cell research & therapy |
container_volume | 15 |
creator | Shin, Eun-Young Jeong, Suji Lee, Jeoung Eun Jeong, Dong Seok Han, Dong Keun Hong, Seok-Ho Lee, Dong Ryul |
description | Currently, no approved stem cell-based therapies for preserving ovarian function during aging. To solve this problem, we developed a long-term treatment for human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs). We investigated whether the cells retained their ability to resist ovarian aging, which leads to delayed reproductive senescence.
In a middle-aged female model undergoing natural aging, we analyzed whether hESC-MPCs benefit the long-term maintenance of reproductive fecundity and ovarian reservoirs and how their transplantation regulates ovarian function.
The number of primordial follicles and mice with regular estrous cycles were increased in perimenopausal mice who underwent multiple introductions of hESC-MPCs compared to age-matched controls. The estradiol levels in the hESC-MPCs group were restored to those in the young and adult groups. Embryonic development and live birth rates were higher in the hESC-MPC group than in the control group, suggesting that hESC-MPCs delayed ovarian senescence. In addition to their direct effects on the ovary, multiple-treatments with hESC-MPCs reduced ovarian fibrosis by downregulating inflammation and fibrosis-related genes via the suppression of myeloid-derived suppressor cells (MDSCs) produced in the bone marrow.
Multiple introductions of hESC-MPCs could be a useful approach to prevent female reproductive senescence and that these cells are promising sources for cell therapy to postpone the ovarian aging and retain fecundity in perimenopausal women. |
doi_str_mv | 10.1186/s13287-024-03684-6 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_5d9de890cdc7471d9a21026a76c86cee</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A785077778</galeid><doaj_id>oai_doaj_org_article_5d9de890cdc7471d9a21026a76c86cee</doaj_id><sourcerecordid>A785077778</sourcerecordid><originalsourceid>FETCH-LOGICAL-c580t-481918e2f46e5d176d9f52319fa1f0bafe872e6f7fba08c00272a7aab544ff3c3</originalsourceid><addsrcrecordid>eNptk9tu1DAQhiMEolXpC3CBLCEhuEixncR2rlBVcahUhMTh2vI646yrxF5sp7DvxQMy25bSRTgXccbf_BP_9lTVU0ZPGFPidWYNV7KmvK1pI1RbiwfVIZOdrEXH-MN784PqOOdLiqNpKBXt4-qgUW3TcN4cVr8-LlPxmwlISWDKDKFk8sOXNVkvswkE5lXaxuAtyQVmYmGa6gGSv4KBzJAh2PV2NhPZpDhC8CWmayZjAFfTDitrIA5S8ZMvW2LCQOKVSR7F3RJs8TGQ6MgGRbF63Jglo97sLZAlYKkx-jCSYMqSMG5G_HpSPXJmynB8-z6qvr17-_XsQ33x6f352elFbTtFS90q1jMF3LUCuoFJMfSu4w3rnWGOrowDJTkIJ93KUGUp5ZIbacyqa1vnGtscVec3ukM0l3qDP2jSVkfj9XUgplEb3JedQHdDP4DqqR2sbCUbesMZ5cJIYZWwAKj15kZrs6xmGCwajfvZE91fCX6tx3ilGe0ZVbxHhZe3Cil-XyAXPfu8M9sEiEvWiMimEZwJRJ__g17GJQX0CqlOKDRGyL_UaHAHPriIhe1OVJ9K1VGJQyF18h8KnwHwkGIA5zG-l_BqLwGZAj_LiAeb9fmXz_vsi3vsGsxU1jlOy-5W5H2Q34A2xZwTuDvnGNW7htA3DaGxIfR1Q-idDc_ue36X8uf6N78BEK4JjA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2956881967</pqid></control><display><type>article</type><title>Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved the fertility and ovarian function of perimenopausal mice undergoing natural aging</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Shin, Eun-Young ; Jeong, Suji ; Lee, Jeoung Eun ; Jeong, Dong Seok ; Han, Dong Keun ; Hong, Seok-Ho ; Lee, Dong Ryul</creator><creatorcontrib>Shin, Eun-Young ; Jeong, Suji ; Lee, Jeoung Eun ; Jeong, Dong Seok ; Han, Dong Keun ; Hong, Seok-Ho ; Lee, Dong Ryul</creatorcontrib><description>Currently, no approved stem cell-based therapies for preserving ovarian function during aging. To solve this problem, we developed a long-term treatment for human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs). We investigated whether the cells retained their ability to resist ovarian aging, which leads to delayed reproductive senescence.
In a middle-aged female model undergoing natural aging, we analyzed whether hESC-MPCs benefit the long-term maintenance of reproductive fecundity and ovarian reservoirs and how their transplantation regulates ovarian function.
The number of primordial follicles and mice with regular estrous cycles were increased in perimenopausal mice who underwent multiple introductions of hESC-MPCs compared to age-matched controls. The estradiol levels in the hESC-MPCs group were restored to those in the young and adult groups. Embryonic development and live birth rates were higher in the hESC-MPC group than in the control group, suggesting that hESC-MPCs delayed ovarian senescence. In addition to their direct effects on the ovary, multiple-treatments with hESC-MPCs reduced ovarian fibrosis by downregulating inflammation and fibrosis-related genes via the suppression of myeloid-derived suppressor cells (MDSCs) produced in the bone marrow.
Multiple introductions of hESC-MPCs could be a useful approach to prevent female reproductive senescence and that these cells are promising sources for cell therapy to postpone the ovarian aging and retain fecundity in perimenopausal women.</description><identifier>ISSN: 1757-6512</identifier><identifier>EISSN: 1757-6512</identifier><identifier>DOI: 10.1186/s13287-024-03684-6</identifier><identifier>PMID: 38433223</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>17β-Estradiol ; Aging ; Apoptosis ; Bone marrow ; Cell growth ; Cell therapy ; Comparative analysis ; Cytokines ; Embryo cells ; Embryogenesis ; Embryonic stem cells ; Estradiol ; Ethylenediaminetetraacetic acid ; Experiments ; Fecundity ; Females ; Fertility ; Fertility preservation of natural aging female ; Fibrosis ; Follicles ; Human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs) ; Laboratory animals ; Menopause ; Myeloid-derived suppressor cells (MDSCs) ; Ovarian function ; Ovaries ; Progenitor cells ; Reproductive senescence ; Reproductive status ; Senescence ; Stem cells ; Suppressor cells ; Transplantation</subject><ispartof>Stem cell research & therapy, 2024-03, Vol.15 (1), p.58-58, Article 58</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c580t-481918e2f46e5d176d9f52319fa1f0bafe872e6f7fba08c00272a7aab544ff3c3</cites><orcidid>0000-0003-1534-4810</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910829/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2956881967?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38433223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Eun-Young</creatorcontrib><creatorcontrib>Jeong, Suji</creatorcontrib><creatorcontrib>Lee, Jeoung Eun</creatorcontrib><creatorcontrib>Jeong, Dong Seok</creatorcontrib><creatorcontrib>Han, Dong Keun</creatorcontrib><creatorcontrib>Hong, Seok-Ho</creatorcontrib><creatorcontrib>Lee, Dong Ryul</creatorcontrib><title>Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved the fertility and ovarian function of perimenopausal mice undergoing natural aging</title><title>Stem cell research & therapy</title><addtitle>Stem Cell Res Ther</addtitle><description>Currently, no approved stem cell-based therapies for preserving ovarian function during aging. To solve this problem, we developed a long-term treatment for human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs). We investigated whether the cells retained their ability to resist ovarian aging, which leads to delayed reproductive senescence.
In a middle-aged female model undergoing natural aging, we analyzed whether hESC-MPCs benefit the long-term maintenance of reproductive fecundity and ovarian reservoirs and how their transplantation regulates ovarian function.
The number of primordial follicles and mice with regular estrous cycles were increased in perimenopausal mice who underwent multiple introductions of hESC-MPCs compared to age-matched controls. The estradiol levels in the hESC-MPCs group were restored to those in the young and adult groups. Embryonic development and live birth rates were higher in the hESC-MPC group than in the control group, suggesting that hESC-MPCs delayed ovarian senescence. In addition to their direct effects on the ovary, multiple-treatments with hESC-MPCs reduced ovarian fibrosis by downregulating inflammation and fibrosis-related genes via the suppression of myeloid-derived suppressor cells (MDSCs) produced in the bone marrow.
Multiple introductions of hESC-MPCs could be a useful approach to prevent female reproductive senescence and that these cells are promising sources for cell therapy to postpone the ovarian aging and retain fecundity in perimenopausal women.</description><subject>17β-Estradiol</subject><subject>Aging</subject><subject>Apoptosis</subject><subject>Bone marrow</subject><subject>Cell growth</subject><subject>Cell therapy</subject><subject>Comparative analysis</subject><subject>Cytokines</subject><subject>Embryo cells</subject><subject>Embryogenesis</subject><subject>Embryonic stem cells</subject><subject>Estradiol</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Experiments</subject><subject>Fecundity</subject><subject>Females</subject><subject>Fertility</subject><subject>Fertility preservation of natural aging female</subject><subject>Fibrosis</subject><subject>Follicles</subject><subject>Human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs)</subject><subject>Laboratory animals</subject><subject>Menopause</subject><subject>Myeloid-derived suppressor cells (MDSCs)</subject><subject>Ovarian function</subject><subject>Ovaries</subject><subject>Progenitor cells</subject><subject>Reproductive senescence</subject><subject>Reproductive status</subject><subject>Senescence</subject><subject>Stem cells</subject><subject>Suppressor cells</subject><subject>Transplantation</subject><issn>1757-6512</issn><issn>1757-6512</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptk9tu1DAQhiMEolXpC3CBLCEhuEixncR2rlBVcahUhMTh2vI646yrxF5sp7DvxQMy25bSRTgXccbf_BP_9lTVU0ZPGFPidWYNV7KmvK1pI1RbiwfVIZOdrEXH-MN784PqOOdLiqNpKBXt4-qgUW3TcN4cVr8-LlPxmwlISWDKDKFk8sOXNVkvswkE5lXaxuAtyQVmYmGa6gGSv4KBzJAh2PV2NhPZpDhC8CWmayZjAFfTDitrIA5S8ZMvW2LCQOKVSR7F3RJs8TGQ6MgGRbF63Jglo97sLZAlYKkx-jCSYMqSMG5G_HpSPXJmynB8-z6qvr17-_XsQ33x6f352elFbTtFS90q1jMF3LUCuoFJMfSu4w3rnWGOrowDJTkIJ93KUGUp5ZIbacyqa1vnGtscVec3ukM0l3qDP2jSVkfj9XUgplEb3JedQHdDP4DqqR2sbCUbesMZ5cJIYZWwAKj15kZrs6xmGCwajfvZE91fCX6tx3ilGe0ZVbxHhZe3Cil-XyAXPfu8M9sEiEvWiMimEZwJRJ__g17GJQX0CqlOKDRGyL_UaHAHPriIhe1OVJ9K1VGJQyF18h8KnwHwkGIA5zG-l_BqLwGZAj_LiAeb9fmXz_vsi3vsGsxU1jlOy-5W5H2Q34A2xZwTuDvnGNW7htA3DaGxIfR1Q-idDc_ue36X8uf6N78BEK4JjA</recordid><startdate>20240303</startdate><enddate>20240303</enddate><creator>Shin, Eun-Young</creator><creator>Jeong, Suji</creator><creator>Lee, Jeoung Eun</creator><creator>Jeong, Dong Seok</creator><creator>Han, Dong Keun</creator><creator>Hong, Seok-Ho</creator><creator>Lee, Dong Ryul</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1534-4810</orcidid></search><sort><creationdate>20240303</creationdate><title>Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved the fertility and ovarian function of perimenopausal mice undergoing natural aging</title><author>Shin, Eun-Young ; Jeong, Suji ; Lee, Jeoung Eun ; Jeong, Dong Seok ; Han, Dong Keun ; Hong, Seok-Ho ; Lee, Dong Ryul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c580t-481918e2f46e5d176d9f52319fa1f0bafe872e6f7fba08c00272a7aab544ff3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>17β-Estradiol</topic><topic>Aging</topic><topic>Apoptosis</topic><topic>Bone marrow</topic><topic>Cell growth</topic><topic>Cell therapy</topic><topic>Comparative analysis</topic><topic>Cytokines</topic><topic>Embryo cells</topic><topic>Embryogenesis</topic><topic>Embryonic stem cells</topic><topic>Estradiol</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Experiments</topic><topic>Fecundity</topic><topic>Females</topic><topic>Fertility</topic><topic>Fertility preservation of natural aging female</topic><topic>Fibrosis</topic><topic>Follicles</topic><topic>Human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs)</topic><topic>Laboratory animals</topic><topic>Menopause</topic><topic>Myeloid-derived suppressor cells (MDSCs)</topic><topic>Ovarian function</topic><topic>Ovaries</topic><topic>Progenitor cells</topic><topic>Reproductive senescence</topic><topic>Reproductive status</topic><topic>Senescence</topic><topic>Stem cells</topic><topic>Suppressor cells</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Eun-Young</creatorcontrib><creatorcontrib>Jeong, Suji</creatorcontrib><creatorcontrib>Lee, Jeoung Eun</creatorcontrib><creatorcontrib>Jeong, Dong Seok</creatorcontrib><creatorcontrib>Han, Dong Keun</creatorcontrib><creatorcontrib>Hong, Seok-Ho</creatorcontrib><creatorcontrib>Lee, Dong Ryul</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Stem cell research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Eun-Young</au><au>Jeong, Suji</au><au>Lee, Jeoung Eun</au><au>Jeong, Dong Seok</au><au>Han, Dong Keun</au><au>Hong, Seok-Ho</au><au>Lee, Dong Ryul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved the fertility and ovarian function of perimenopausal mice undergoing natural aging</atitle><jtitle>Stem cell research & therapy</jtitle><addtitle>Stem Cell Res Ther</addtitle><date>2024-03-03</date><risdate>2024</risdate><volume>15</volume><issue>1</issue><spage>58</spage><epage>58</epage><pages>58-58</pages><artnum>58</artnum><issn>1757-6512</issn><eissn>1757-6512</eissn><abstract>Currently, no approved stem cell-based therapies for preserving ovarian function during aging. To solve this problem, we developed a long-term treatment for human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs). We investigated whether the cells retained their ability to resist ovarian aging, which leads to delayed reproductive senescence.
In a middle-aged female model undergoing natural aging, we analyzed whether hESC-MPCs benefit the long-term maintenance of reproductive fecundity and ovarian reservoirs and how their transplantation regulates ovarian function.
The number of primordial follicles and mice with regular estrous cycles were increased in perimenopausal mice who underwent multiple introductions of hESC-MPCs compared to age-matched controls. The estradiol levels in the hESC-MPCs group were restored to those in the young and adult groups. Embryonic development and live birth rates were higher in the hESC-MPC group than in the control group, suggesting that hESC-MPCs delayed ovarian senescence. In addition to their direct effects on the ovary, multiple-treatments with hESC-MPCs reduced ovarian fibrosis by downregulating inflammation and fibrosis-related genes via the suppression of myeloid-derived suppressor cells (MDSCs) produced in the bone marrow.
Multiple introductions of hESC-MPCs could be a useful approach to prevent female reproductive senescence and that these cells are promising sources for cell therapy to postpone the ovarian aging and retain fecundity in perimenopausal women.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38433223</pmid><doi>10.1186/s13287-024-03684-6</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1534-4810</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1757-6512 |
ispartof | Stem cell research & therapy, 2024-03, Vol.15 (1), p.58-58, Article 58 |
issn | 1757-6512 1757-6512 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_5d9de890cdc7471d9a21026a76c86cee |
source | Publicly Available Content Database; PubMed Central |
subjects | 17β-Estradiol Aging Apoptosis Bone marrow Cell growth Cell therapy Comparative analysis Cytokines Embryo cells Embryogenesis Embryonic stem cells Estradiol Ethylenediaminetetraacetic acid Experiments Fecundity Females Fertility Fertility preservation of natural aging female Fibrosis Follicles Human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs) Laboratory animals Menopause Myeloid-derived suppressor cells (MDSCs) Ovarian function Ovaries Progenitor cells Reproductive senescence Reproductive status Senescence Stem cells Suppressor cells Transplantation |
title | Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved the fertility and ovarian function of perimenopausal mice undergoing natural aging |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A40%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20treatments%20with%20human%20embryonic%20stem%20cell-derived%20mesenchymal%20progenitor%20cells%20preserved%20the%20fertility%20and%20ovarian%20function%20of%20perimenopausal%20mice%20undergoing%20natural%20aging&rft.jtitle=Stem%20cell%20research%20&%20therapy&rft.au=Shin,%20Eun-Young&rft.date=2024-03-03&rft.volume=15&rft.issue=1&rft.spage=58&rft.epage=58&rft.pages=58-58&rft.artnum=58&rft.issn=1757-6512&rft.eissn=1757-6512&rft_id=info:doi/10.1186/s13287-024-03684-6&rft_dat=%3Cgale_doaj_%3EA785077778%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c580t-481918e2f46e5d176d9f52319fa1f0bafe872e6f7fba08c00272a7aab544ff3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2956881967&rft_id=info:pmid/38433223&rft_galeid=A785077778&rfr_iscdi=true |